Presymptomatic studies in genetic frontotemporal dementia

Yazar: Rohrer, J.D., Warren, J.D., Fox, N.C., Rossor, M.N.
Baskı/Yayın Bilgisi 2013

Cerebral and cerebellar atrophy on serial magnetic resonance imaging in an initially symptom free subject at risk of familial prion disease.

Yazar: Fox, N. C., Freeborough, P. A., Mekkaoui, K. F., Stevens, J. M., Rossor, M. N.
Baskı/Yayın Bilgisi 1997

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

Yazar: Schott, J.M., Bartlett, J.W., Barnes, J., Leung, K.K., Ourselin, S., Fox, N.C.
Baskı/Yayın Bilgisi 2010

Brain-water diffusion coefficients reflect the severity of inherited prion disease

Yazar: Hyare, H., Wroe, S., Siddique, D., Webb, T., Fox, N. C., Stevens, J., Collinge, J., Yousry, T., Thornton, J. S.
Baskı/Yayın Bilgisi 2010

Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study

Yazar: Gordon, E., Rohrer, J. D., Kim, L. G., Omar, R., Rossor, M. N., Fox, N. C., Warren, J. D.
Baskı/Yayın Bilgisi 2010

Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease

Yazar: Henley, S.M.D., Ridgway, G.R., Scahill, R.I., Klöppel, S., Tabrizi, S.J., Fox, N.C., Kassubek, J.
Yayımlandı AJNR Am J Neuroradiol (2010)

Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration

Yazar: Rohrer, J D., Warren, J D., Modat, M, Ridgway, G R., Douiri, A, Rossor, M N., Ourselin, S, Fox, N C.
Baskı/Yayın Bilgisi 2009

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

Yazar: Paterson, R W, Bartlett, J W, Blennow, K, Fox, N C, Shaw, L M, Trojanowski, J Q, Zetterberg, H, Schott, J M
Baskı/Yayın Bilgisi 2014

Biomarkers in dementia: clinical utility and new directions

Yazar: Ahmed, R M, Paterson, R W, Warren, J D, Zetterberg, H, O'Brien, J T, Fox, N C, Halliday, G M, Schott, J M
Yayımlandı J Neurol Neurosurg Psychiatry (2014)

Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures

Yazar: Henneman, W J.P., Sluimer, J D., Barnes, J, van der Flier, W M., Sluimer, I C., Fox, N C., Scheltens, P, Vrenken, H, Barkhof, F
Baskı/Yayın Bilgisi 2009

Operationalizing hippocampal volume as an enrichment biomarker for amnestic MCI trials: effect of algorithm, test-retest variability and cut-point on trial cost, duration and sampl...

Yazar: Yu, P., Sun, J., Wolz, R., Stephenson, D., Brewer, J., Fox, N.C., Cole, P.E., Jack, C.R., Hill, D.L.G., Schwarz, A.J.
Baskı/Yayın Bilgisi 2013

Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study

Yazar: Hobbs, N.Z., Barnes, J., Frost, C., Henley, S.M.D., Wild, E.J., Macdonald, K., Barker, R.A., Scahill, R.I., Fox, N.C., Tabrizi, S.J.
Yayımlandı AJNR Am J Neuroradiol (2010)

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

Yazar: Henneman, W J.P., Vrenken, H, Barnes, J, Sluimer, I C., Verwey, N A., Blankenstein, M A., Klein, M, Fox, N C., Scheltens, P, Barkhof, F, van der Flier, W M.
Baskı/Yayın Bilgisi 2009

Conversion of amyloid positive and negative MCI to AD over 3 years: An (11)C-PIB PET study

Yazar: Okello, A, Koivunen, J, Edison, P, Archer, H A., Turkheimer, F E., Någren, K, Bullock, R, Walker, Z, Kennedy, A, Fox, N C., Rossor, M N., Rinne, J O., Brooks, D J.
Baskı/Yayın Bilgisi 2009

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

Yazar: Magdalinou, N K, Paterson, R W, Schott, J M, Fox, N C, Mummery, C, Blennow, K, Bhatia, K, Morris, H R, Giunti, P, Warner, T T, de Silva, R, Lees, A J, Zetterberg, H
Yayımlandı J Neurol Neurosurg Psychiatry (2015)

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology

Yazar: Paterson, R W, Heywood, W E, Heslegrave, A J, Magdalinou, N K, Andreasson, U, Sirka, E, Bliss, E, Slattery, C F, Toombs, J, Svensson, J, Johansson, P, Fox, N C, Zetterberg, H, Mills, K, Schott, J M
Yayımlandı Transl Psychiatry (2016)

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

Yazar: Salloway, S, Sperling, R, Gilman, S, Fox, N C., Blennow, K, Raskind, M, Sabbagh, M, Honig, L S., Doody, R, van Dyck, C H., Mulnard, R, Barakos, J, Gregg, K M., Liu, E, Lieberburg, I, Schenk, D, Black, R, Grundman, M
Baskı/Yayın Bilgisi 2009

Magnetization Transfer Ratio in Alzheimer Disease: Comparison with Volumetric Measurements

Yazar: Ridha, B.H., Symms, M.R., Tozer, D.J., Stockton, K.C., Frost, C., Siddique, M.M., Lewis, E.B., MacManus, D.G., Boulby, P.A., Barker, G.J., Rossor, M.N., Fox, N.C., Tofts, P.S.
Yayımlandı AJNR Am J Neuroradiol (2007)

The heritability and genetics of frontotemporal lobar degeneration

Yazar: Rohrer, J D., Guerreiro, R, Vandrovcova, J, Uphill, J, Reiman, D, Beck, J, Isaacs, A M., Authier, A, Ferrari, R, Fox, N C., Mackenzie, I R.A., Warren, J D., de Silva, R, Holton, J, Revesz, T, Hardy, J, Mead, S, Rossor, M N.
Baskı/Yayın Bilgisi 2009

Impact of APOE4-CSF Aβ interaction on hippocampal volume loss over 1 year in MCI

Yazar: Chiang, G.C., Insel, P.S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S.T., Thompson, P.M., Reiman, E.M., Jack, C.R., Fox, N.C., Jagust, W.J., Harvey, D.J., Beckett, L.A., Gamst, A., Aisen, P.S., Petersen, R.C., Weiner, M.W.
Baskı/Yayın Bilgisi 2011